Analysis & Opinions
January 18, 2013
Exelixis, Inc. (EXEL) recently announced that it has received a notice from its partner, Roche Holding (RHHBY), ...
October 23, 2012
It's been a bad day for the market after the morning's trading. The Nasdaq has decreased 0.8%; the S&P 500 is down ...
November 03, 2011
Dendreon's Provenge continues to shape up as a major disappointment.
June 07, 2011
Investors shouldn't be spooked by the normal post-ASCO sell-off
July 06, 2010
The stock market may have had a terrible performance in June, but many stocks have defied the negative market trend.
May 13, 2010
Adaptive design is an idea whose time has come, and investors in biotechs and pharmaceuticals should stand to benefit.
November 18, 2009
Fourth healthcare stocks that have brushed aside any potential adversity that could arise from future legislation ...